淋巴瘤
医学
胃肠道
放射治疗
边缘地带
内科学
病态的
化疗
入射(几何)
胃肠病学
肿瘤科
B细胞
免疫学
抗体
光学
物理
出处
期刊:Journal of Leukemia and Lymphoma
日期:2018-08-25
卷期号:27 (8): 505-509
标识
DOI:10.3760/cma.j.issn.1009-9921.2018.08.016
摘要
The incidence of primary intestinal lymphoma (PIL) in primary gastrointestinal lymphoma (PGIL) is much lower than that of primary gastric lymphoma (PGL). Treatment strategies for PGL have been normalized, but there are still controversies concerning about the diagnosis criteria and optimal treatment of PIL. The lesions are mainly found in intestinal tract, and the most common involvement is ileocecal junction. The pathological types are derived from B-cell and diffuse large B-cell lymphoma (DLBCL) is the most common type, followed by extra-nodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Surgery, chemotherapy, radiotherapy, antibiotics and monoclonal antibody therapy could be used as the monotherapy or different combined therapies, however, the final conclusion has not been reached in the treatment of PIL, accompanied by various influencing factors for prognosis. This review discusses the diagnosis criteria, clinical features, optimal treatment and prognostic factors of PIL. The diagnosis criteria and the optimal treatment will be put more emphasis.
Key words:
Gastrointestinal tract; Lymphoma, B-cell; Lymphoma, T-cell; Prognosis
科研通智能强力驱动
Strongly Powered by AbleSci AI